{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:14:58Z","timestamp":1791220498623,"version":"4.1.0"},"reference-count":85,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013362","name":"Cancer Research Switzerland","doi-asserted-by":"publisher","award":["KFS-5557-02-2022"],"award-info":[{"award-number":["KFS-5557-02-2022"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Cancer Research Switzerland","doi-asserted-by":"publisher","award":["310030M_204518"],"award-info":[{"award-number":["310030M_204518"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Cancer Research Switzerland","doi-asserted-by":"publisher","award":["2022.0470"],"award-info":[{"award-number":["2022.0470"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Cancer Research Switzerland","doi-asserted-by":"publisher","award":["2019.0385"],"award-info":[{"award-number":["2019.0385"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013362","name":"Cancer Research Switzerland","doi-asserted-by":"publisher","award":["#101023999"],"award-info":[{"award-number":["#101023999"]}],"id":[{"id":"10.13039\/501100013362","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swiss National Science Foundation","award":["KFS-5557-02-2022"],"award-info":[{"award-number":["KFS-5557-02-2022"]}]},{"name":"Swiss National Science Foundation","award":["310030M_204518"],"award-info":[{"award-number":["310030M_204518"]}]},{"name":"Swiss National Science Foundation","award":["2022.0470"],"award-info":[{"award-number":["2022.0470"]}]},{"name":"Swiss National Science Foundation","award":["2019.0385"],"award-info":[{"award-number":["2019.0385"]}]},{"name":"Swiss National Science Foundation","award":["#101023999"],"award-info":[{"award-number":["#101023999"]}]},{"name":"Swiss Government Excellence Scholarship (ESKAS)","award":["KFS-5557-02-2022"],"award-info":[{"award-number":["KFS-5557-02-2022"]}]},{"name":"Swiss Government Excellence Scholarship (ESKAS)","award":["310030M_204518"],"award-info":[{"award-number":["310030M_204518"]}]},{"name":"Swiss Government Excellence Scholarship (ESKAS)","award":["2022.0470"],"award-info":[{"award-number":["2022.0470"]}]},{"name":"Swiss Government Excellence Scholarship (ESKAS)","award":["2019.0385"],"award-info":[{"award-number":["2019.0385"]}]},{"name":"Swiss Government Excellence Scholarship (ESKAS)","award":["#101023999"],"award-info":[{"award-number":["#101023999"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["KFS-5557-02-2022"],"award-info":[{"award-number":["KFS-5557-02-2022"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["310030M_204518"],"award-info":[{"award-number":["310030M_204518"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["2022.0470"],"award-info":[{"award-number":["2022.0470"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["2019.0385"],"award-info":[{"award-number":["2019.0385"]}]},{"name":"Marie Sk\u0142odowska-Curie Individual Fellowship","award":["#101023999"],"award-info":[{"award-number":["#101023999"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomolecules"],"abstract":"<jats:p>Endocrine-disrupting chemicals (EDCs) may impact the development of prostate cancer (PCa) by altering the steroid metabolism. Although their exact mechanism of action in controlling tumor growth is not known, EDCs may inhibit steroidogenic enzymes such as CYP17A1 or CYP19A1 which are involved in the production of androgens or estrogens. High levels of circulating androgens are linked to PCa in men and Polycystic Ovary Syndrome (PCOS) in women. Essential oils or their metabolites, like lavender oil and tea tree oil, have been reported to act as potential EDCs and contribute towards sex steroid imbalance in cases of prepubertal gynecomastia in boys and premature thelarche in girls due to the exposure to lavender-based fragrances. We screened a range of EO components to determine their effects on CYP17A1 and CYP19A1. Computational docking was performed to predict the binding of essential oils with CYP17A1 and CYP19A1. Functional assays were performed using the radiolabeled substrates or Liquid Chromatography\u2013High-Resolution Mass Spectrometry and cell viability assays were carried out in LNCaP cells. Many of the tested compounds bind close to the active site of CYP17A1, and (+)-Cedrol had the best binding with CYP17A1 and CYP19A1. Eucalyptol, Dihydro-\u03b2-Ionone, and (\u2212)-\u03b1-pinene showed 20% to 40% inhibition of dehydroepiandrosterone production; and some compounds also effected CYP19A1. Extensive use of these essential oils in various beauty and hygiene products is common, but only limited knowledge about their potential detrimental side effects exists. Our results suggest that prolonged exposure to some of these essential oils may result in steroid imbalances. On the other hand, due to their effect on lowering androgen output and ability to bind at the active site of steroidogenic cytochrome P450s, these compounds may provide design ideas for novel compounds against hyperandrogenic disorders such as PCa and PCOS.<\/jats:p>","DOI":"10.3390\/biom14020203","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T03:36:17Z","timestamp":1707363377000},"page":"203","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Effect of Essential Oil Components on the Activity of Steroidogenic Cytochrome P450"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6818-0931","authenticated-orcid":false,"given":"Katyayani","family":"Sharma","sequence":"first","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Lanzilotto","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jibira","family":"Yakubu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Therkelsen","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarissa Daniela","family":"V\u00f6egel","sequence":"additional","affiliation":[{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of Nephrology and Hypertension, University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therina","family":"Du Toit","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"},{"name":"Department of Nephrology and Hypertension, University Hospital Inselspital, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8040-2998","authenticated-orcid":false,"given":"Flemming Steen","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Drug Design and Pharmacology, University of Copenhagen, 2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-5902","authenticated-orcid":false,"given":"Amit V.","family":"Pandey","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetology and Metabolism, Department of Pediatrics, University Children\u2019s Hospital, Inselspital, University of Bern, 3010 Bern, Switzerland"},{"name":"Translational Hormone Research Program, Department of Biomedical Research, University of Bern, 3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,8]]},"reference":[{"key":"ref_1","unstructured":"Ricke, S.C., Atungulu, G.G., Rainwater, C.E., and Park, S.H. (2018). Food and Feed Safety Systems and Analysis, Academic Press."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cimino, C., Maurel, O.M., Musumeci, T., Bonaccorso, A., Drago, F., Souto, E.M.B., Pignatello, R., and Carbone, C. (2021). Essential Oils: Pharmaceutical Applications and Encapsulation Strategies into Lipid-Based Delivery Systems. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13030327"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/DER.0000000000000175","article-title":"Essential Oils, Part I: Introduction","volume":"27","author":"Schmidt","year":"2016","journal-title":"Dermatitis"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.fct.2007.09.106","article-title":"Biological effects of essential oils\u2014A review","volume":"46","author":"Bakkali","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"ref_5","unstructured":"Shagufta, P., and Areej Mohammad, A.-T. (2020). Terpenes and Terpenoids, IntechOpen."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Sharmeen, J.B., Mahomoodally, F.M., Zengin, G., and Maggi, F. (2021). Essential Oils as Natural Sources of Fragrance Compounds for Cosmetics and Cosmeceuticals. Molecules, 26.","DOI":"10.3390\/molecules26030666"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/DER.0000000000000193","article-title":"Essential Oils, Part III: Chemical Composition","volume":"27","author":"Schmidt","year":"2016","journal-title":"Dermatitis"},{"key":"ref_8","first-page":"291","article-title":"Essential Oils and Health","volume":"93","author":"Ramsey","year":"2020","journal-title":"Yale J. Biol. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.apjtb.2015.05.007","article-title":"Essential oils used in aromatherapy: A systemic review","volume":"5","author":"Ali","year":"2015","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijfoodmicro.2004.03.022","article-title":"Essential oils: Their antibacterial properties and potential applications in foods\u2014A review","volume":"94","author":"Burt","year":"2004","journal-title":"Int. J. Food Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2174\/1389450119666181031122917","article-title":"Essential Oils: An Impending Substitute of Synthetic Antimicrobial Agents to Overcome Antimicrobial Resistance","volume":"20","author":"Mittal","year":"2019","journal-title":"Curr. Drug Targets"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-019-09521-z","article-title":"Endocrine disrupting chemicals: Exposure, effects on human health, mechanism of action, models for testing and strategies for prevention","volume":"21","author":"Yilmaz","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1056\/NEJMoa064725","article-title":"Prepubertal gynecomastia linked to lavender and tea tree oils","volume":"356","author":"Henley","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1210\/er.2010-0013","article-title":"The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders","volume":"32","author":"Miller","year":"2011","journal-title":"Endocr. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1210\/jcem-63-3-789","article-title":"Assignment of the gene for adrenal P450c17 (steroid 17 alpha-hydroxylase\/17,20 lyase) to human chromosome 10","volume":"63","author":"Matteson","year":"1986","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.84.2.407","article-title":"Cytochrome P450c17 (steroid 17 alpha-hydroxylase\/17,20 lyase): Cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues","volume":"84","author":"Chung","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1074\/jbc.M114.627265","article-title":"Structural and kinetic basis of steroid 17alpha,20-lyase activity in teleost fish cytochrome P450 17A1 and its absence in cytochrome P450 17A2","volume":"290","author":"Pallan","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1126\/science.3535074","article-title":"Expression of bovine 17 alpha-hydroxylase cytochrome P-450 cDNA in nonsteroidogenic (COS 1) cells","volume":"234","author":"Zuber","year":"1986","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.1016\/S0021-9258(19)83930-3","article-title":"Role of electron transport in the regulation of the lyase activity of C21 side-chain cleavage P-450 from porcine adrenal and testicular microsomes","volume":"261","author":"Yanagibashi","year":"1986","journal-title":"J. Biol. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.pharmthera.2013.01.010","article-title":"NADPH P450 oxidoreductase: Structure, function, and pathology of diseases","volume":"138","author":"Pandey","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1074\/jbc.273.6.3158","article-title":"Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron transfer","volume":"273","author":"Auchus","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"13265","DOI":"10.1074\/jbc.M414673200","article-title":"Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17","volume":"280","author":"Pandey","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10619","DOI":"10.1073\/pnas.92.23.10619","article-title":"Serine phosphorylation of human P450c17 increases 17,20-lyase activity: Implications for adrenarche and the polycystic ovary syndrome","volume":"92","author":"Zhang","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.M209527200","article-title":"Protein phosphatase 2A and phosphoprotein SET regulate androgen production by P450c17","volume":"278","author":"Pandey","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/en.2010-0093","article-title":"Impact of differential P450c17 phosphorylation by cAMP stimulation and by starvation conditions on enzyme activities and androgen production in NCI-H295R cells","volume":"151","author":"Kempna","year":"2010","journal-title":"Endocrinology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1210\/en.2009-1247","article-title":"Human cytochrome p450c17: Single step purification and phosphorylation of serine 258 by protein kinase a","volume":"151","author":"Wang","year":"2010","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.mce.2014.09.010","article-title":"The post-translational regulation of 17,20 lyase activity","volume":"408","author":"Miller","year":"2015","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"23903","DOI":"10.1074\/jbc.M113.460048","article-title":"Phosphorylation of human cytochrome P450c17 by p38alpha selectively increases 17,20 lyase activity and androgen biosynthesis","volume":"288","author":"Tee","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1677\/ERC-08-0043","article-title":"Endocrine disruptors and prostate cancer risk","volume":"15","author":"Prins","year":"2008","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/aps.2014.18","article-title":"Androgen receptor: Structure, role in prostate cancer and drug discovery","volume":"36","author":"Tan","year":"2015","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/jcb.29515","article-title":"Comparison of the roles of estrogens and androgens in breast cancer and prostate cancer","volume":"121","author":"Liu","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"32952","DOI":"10.1074\/jbc.M114.610998","article-title":"Structures of human steroidogenic cytochrome P450 17A1 with substrates","volume":"289","author":"Petrunak","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsbmb.2009.09.012","article-title":"X-ray structure of human aromatase reveals an androgen-specific active site","volume":"118","author":"Ghosh","year":"2010","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1021\/bi400669h","article-title":"Structural basis for the functional roles of critical residues in human cytochrome p450 aromatase","volume":"52","author":"Lo","year":"2013","journal-title":"Biochemistry"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nature07614","article-title":"Structural basis for androgen specificity and oestrogen synthesis in human aromatase","volume":"457","author":"Ghosh","year":"2009","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: A software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nature10743","article-title":"Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001","volume":"482","author":"DeVore","year":"2012","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.mce.2016.08.035","article-title":"Structural insights into the function of steroidogenic cytochrome P450 17A1","volume":"441","author":"Yadav","year":"2017","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jsbmb.2018.02.009","article-title":"Testosterone complex and non-steroidal ligands of human aromatase","volume":"181","author":"Ghosh","year":"2018","journal-title":"J. Steroid. Biochem. Mol. Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra Precision Glide:\u2009 Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein\u2212Ligand Complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide:\u2009 A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.mce.2003.12.020","article-title":"Adrenocortical cell lines","volume":"228","author":"Rainey","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_47","first-page":"5488","article-title":"Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis","volume":"50","author":"Gazdar","year":"1990","journal-title":"Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"R155","DOI":"10.1530\/ERC-12-0285","article-title":"Current mouse and cell models in prostate cancer research","volume":"20","author":"Wu","year":"2013","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_49","unstructured":"Markossian, S., Grossman, A., Brimacombe, K., Arkin, M., Auld, D., Austin, C., Baell, J., Chung, T.D.Y., Coussens, N.P., and Dahlin, J.L. (2004). Assay Guidance Manual, Eli Lilly & Company and the National Center for Advancing Translational Sciences."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/fft2.44","article-title":"Guidelines for cell viability assays","volume":"1","author":"Kamiloglu","year":"2020","journal-title":"Food Front."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1021\/jm00013a022","article-title":"Novel Steroidal Inhibitors of Human Cytochrome P45017.alpha.-Hydroxylase-C17,20-lyase): Potential Agents for the Treatment of Prostatic Cancer","volume":"38","author":"Potter","year":"1995","journal-title":"J. Med. Chem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbrc.2016.07.019","article-title":"Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesis","volume":"477","author":"Udhane","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Casta\u00f1o, P.R., Parween, S., and Pandey, A.V. (2019). Bioactivity of Curcumin on the Cytochrome P450 Enzymes of the Steroidogenic Pathway. Int. J. Mol. Sci., 20.","DOI":"10.20944\/preprints201908.0102.v1"},{"key":"ref_54","first-page":"423","article-title":"Regulation of steroidogenesis in NCI-H295 cells: A cellular model of the human fetal adrenal","volume":"7","author":"Staels","year":"1993","journal-title":"Mol. Endocrinol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0039-128X(78)90010-7","article-title":"Trilostane, an orally active inhibitor of steroid biosynthesis","volume":"32","author":"Potts","year":"1978","journal-title":"Steroids"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1590\/S0100-879X2000001000014","article-title":"Biosynthesis and metabolism of steroid hormones by human adrenal carcinomas","volume":"33","author":"Brown","year":"2000","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/en.2002-220813","article-title":"Molecular Target of Endocrine Disruption in Human Luteinizing Granulosa Cells by 2,3,7,8-Tetrachlorodibenzo-p-Dioxin: Inhibition of Estradiol Secretion Due to Decreased 17\u03b1-Hydroxylase\/17,20-Lyase Cytochrome P450 Expression","volume":"144","author":"VandeVoort","year":"2003","journal-title":"Endocrinology"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"McManus, J.M., Bohn, K., Alyamani, M., Chung, Y.M., Klein, E.A., and Sharifi, N. (2019). Rapid and structure-specific cellular uptake of selected steroids. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0224081"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1007\/s00216-022-03881-3","article-title":"Parallel targeted and non-targeted quantitative analysis of steroids in human serum and peritoneal fluid by liquid chromatography high-resolution mass spectrometry","volume":"414","author":"Andrieu","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0022-4731(75)90149-1","article-title":"Studies of human placental aromatase","volume":"6","author":"Siiteri","year":"1975","journal-title":"J. Steroid Biochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/0076-6879(91)06116-K","article-title":"Assay of aromatase activity","volume":"206","author":"Lephart","year":"1991","journal-title":"Methods Enzymol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ffj.3496","article-title":"Essential oil components and cytochrome P450 enzymes: A review","volume":"34","author":"Zehetner","year":"2019","journal-title":"Flavour Fragr. J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cbi.2017.10.021","article-title":"The inhibitory effects of \u03b2-caryophyllene, \u03b2-caryophyllene oxide and \u03b1-humulene on the activities of the main drug-metabolizing enzymes in rat and human liver in vitro","volume":"278","author":"Nguyen","year":"2017","journal-title":"Chem.-Biol. Interact."},{"key":"ref_64","first-page":"S51","article-title":"beta-caryophyllene oxide and trans-nerolidol affect enzyme activity of CYP3A4\u2014In vitro and in silico studies","volume":"68","author":"Bazgier","year":"2019","journal-title":"Physiol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1080\/15287394.2014.955906","article-title":"Inhibitory Effects of Cedrol, \u03b2-Cedrene, and Thujopsene on Cytochrome P450 Enzyme Activities in Human Liver Microsomes","volume":"77","author":"Jeong","year":"2014","journal-title":"J. Toxicol. Environ. Health Part A"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4103\/1008-682X.129133","article-title":"Androgen synthesis inhibitors in the treatment of castration-resistant prostate cancer","volume":"16","author":"Stein","year":"2014","journal-title":"Asian J. Androl."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1172\/JCI87328","article-title":"Androgen receptor antagonism drives cytochrome P450 17A1 inhibitor efficacy in prostate cancer","volume":"127","author":"Norris","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jsbmb.2016.04.021","article-title":"The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature","volume":"163","author":"Bird","year":"2016","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1021\/acs.jmedchem.3c00442","article-title":"Non-steroidal CYP17A1 Inhibitors: Discovery and Assessment","volume":"66","author":"Pandey","year":"2023","journal-title":"J. Med. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1530\/JOE-12-0310","article-title":"Fluconazole inhibits human adrenocortical steroidogenesis in vitro","volume":"215","author":"Hofland","year":"2012","journal-title":"J. Endocrinol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven","volume":"26","author":"Attard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jsbmb.2012.01.001","article-title":"Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys","volume":"129","author":"Yamaoka","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1021\/jm501239f","article-title":"Discovery and Development of Galeterone (TOK-001 or VN\/124-1) for the Treatment of All Stages of Prostate Cancer","volume":"58","author":"Njar","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrurol.2013.274","article-title":"CYP17 inhibitors\u2014Abiraterone, C17,20-lyase inhibitors and multi-targeting agents","volume":"11","author":"Yin","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"29468","DOI":"10.1038\/srep29468","article-title":"Promising Tools in Prostate Cancer Research: Selective Non-Steroidal Cytochrome P450 17A1 Inhibitors","volume":"6","author":"Bonomo","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1039\/C6CC08680B","article-title":"Structure-based optimisation of non-steroidal cytochrome P450 17A1 inhibitors","volume":"53","author":"Larsen","year":"2017","journal-title":"Chem. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Wrobel, T.M., Rogova, O., Andersen, K.L., Yadav, R., Brixius-Anderko, S., Scott, E.E., Olsen, L., Jorgensen, F.S., and Bjorkling, F. (2020). Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21144868"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Wrobel, T.M., Rogova, O., Sharma, K., Rojas Velazquez, M.N., Pandey, A.V., Jorgensen, F.S., Arendrup, F.S., Andersen, K.L., and Bjorkling, F. (2022). Synthesis and Structure-Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents. Biomolecules, 12.","DOI":"10.3390\/biom12020165"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jsbmb.2017.09.007","article-title":"CYP17A1 inhibitor abiraterone, an anti-prostate cancer drug, also inhibits the 21-hydroxylase activity of CYP21A2","volume":"174","author":"Malikova","year":"2017","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1039\/D1OB01178B","article-title":"Effects of fluorine substitution on substrate conversion by cytochromes P450 17A1 and 21A2","volume":"19","author":"Vogt","year":"2021","journal-title":"Org. Biomol. Chem."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1158\/0008-5472.CAN-11-3980","article-title":"Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100","volume":"72","author":"Richards","year":"2012","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1158\/0008-5472.CAN-08-0249","article-title":"Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth","volume":"68","author":"Montgomery","year":"2008","journal-title":"Cancer Res."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Barnard, M., Mostaghel, E.A., Auchus, R.J., and Storbeck, K.-H. (2020). The role of adrenal derived androgens in castration resistant prostate cancer. J. Steroid Biochem. Mol. Biol., 197.","DOI":"10.1016\/j.jsbmb.2019.105506"},{"key":"ref_84","first-page":"348","article-title":"Novel and next-generation androgen receptor\u2013directed therapies for prostate cancer: Beyond abiraterone and enzalutamide","volume":"34","author":"Bambury","year":"2016","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13958","DOI":"10.3390\/ijms140713958","article-title":"Recent Progress in Pharmaceutical Therapies for Castration-Resistant Prostate Cancer","volume":"14","author":"Yin","year":"2013","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/2\/203\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:57:02Z","timestamp":1760104622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-273X\/14\/2\/203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,8]]},"references-count":85,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["biom14020203"],"URL":"https:\/\/doi.org\/10.3390\/biom14020203","relation":{},"ISSN":["2218-273X"],"issn-type":[{"value":"2218-273X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,8]]}}}